C, Hoo boy: New poll shows more people view J&J vaccine as unsafe than safe after FDA "pause" , Allahpundit, 2021-04-15, A potential disaster probably a minor one for us but potentially a major one for the rest of the world. Hopefully when the FDA un-pauses the vaccine next week or whenever public opinion will bounce back. But Iâ€™ll be surprised if it bounces back all the way. And who knows how far itâ€™ll bounce back abroad where theyâ€™ll hear the news about Johnson & Johnson being paused but might not hear the news later that upon further review itâ€™s been deemed overwhelmingly safe after all. Thereâ€™s a silver lining in this data but the cloud is dark.  J&J is down 15 points practically overnight on safety to the point where a plurality now believes itâ€™s unsafe. Like I say maybe thatâ€™ll changed after Fauci declares all is well a week or two from now but I doubt itâ€™ll ever be 52/26 again. The silver lining is that the sudden skepticism about Johnson & Johnson isnâ€™t bleeding over to perceptions of Pfizer and Moderna: Hi Nate weâ€™ve updated the article now with comparison data. No statistically significant differences between pre- and post-announcement sentiment toward other vaccines and the Moderna and Pfizer vaccines are seen about the same as they were in our last poll in late Feb â€” YouGov America (@YouGovAmerica) April 15 2021   Maybe we can message our way back to some degree of public confidence in J&J but other countries probably wonâ€™t be as lucky. The NYT ran a depressing story last night about how news of the pause is reverberating overseas particularly in third-world countries where convincing people to get vaccinated is a heavier lift. Johnson & Johnson was an attractive vaccine for poorer regions because itâ€™s one dose and easier to store just like AstraZeneca is. And now just as with AstraZeneca public faith in J&J has been shaken by a bureaucratic overreaction to reports of rare cases of blood clots. Everyone whoâ€™s been worried this week about vaccine hesitancy spiking in the aftermath of the pause has good reason especially abroad: â€œPeople especially those who were vaccinated felt like they had been tricked in a way â€” they were asking â€˜How do we get rid of the vaccine in our body?â€™â€ said Precious Makiyi a doctor and behavioral scientist in Malawi where health workers have been racing to empty their shelves of nearly expired AstraZeneca doses. â€œWe fought so hard with vaccine messaging but what has happened this past week has brought us back to square zero.â€â€¦ â€œItâ€™s sending vaccine confidence into a craterâ€ Ayoade Alakija a co-chair of the African Unionâ€™s Africa Vaccine Delivery Alliance said of rich countriesâ€™ actions. â€œItâ€™s irresponsible messaging and it speaks to the selfishness of the moment that there wouldnâ€™t be more consultation and communication.â€â€¦ â€œI became even more skeptical when I heard that the United States suspended Johnson & Johnsonâ€ said Lawmond Lawse Nwehla 32 an engineer in Dakar. â€œThey said it was effective and then they stopped it. So I wonder why.â€ â€œMany more people will die without the AstraZeneca and Johnson & Johnson vaccines than with themâ€ the Times noted summarizing the views of medical experts in Africa. But thatâ€™s true here as well as some doctors have been pointing out today on Twitter. Jeremy Faust did some back-of-the-envelope math on how many deaths we might reasonably expect from vaccine-related clotting versus how many deaths we might expect from COVID in demographics that go unvaccinated. You can read his entire thread here but this is the takeaway: Letâ€™s look at the scorecard. If COVID infects all US women ages 20-50: kills 5400 (and actually itâ€™s far higher; recall I used the ridiculously low infection fatality rate of 1 out of 10000 just to make the numbers super conservative) J&J-induced CVS: kills 48. âš–ï¸ğŸ¤” â€” Jeremy Faust MD MS (ER physician) (@jeremyfaust) April 15 2021   Faust allows that the number of vaccine-related clotting cases could turn out to be much higher than we think as the CDC investigates but he doubts it. Enough time has already passed since the pause he argues that doctors nationally will have been looking through their records for recent clotting patients and already reporting to the agency. He wants the pause to end immediately for all men and for women over 50 and to end soon even for women under 50 since J&J might be the only vaccine available to them where they live. Another expert Ashish Jha agrees with Faust that the pause should end now not a week from now: Nearly all the adverse events are in women 18-49 years old Cerebral Venous Sinus Thrombosis (CVST) the clot seen with J&J is known to be more common in young women Suggests that young women probably the group at high risk This actually gave ACIP a smart way forward 2/7 â€” Ashish K. Jha MD MPH (@ashishkjha) April 15 2021  But what about the fact that we have Moderna/Pfizer? They are great. But not easy for everyone.  For many J&J is a life-saver Imagine 54 yo male migrant farm worker with diabetes who can't return for a 2nd shot? Based on what we know today  Would you give him J&J? 4/7 â€” Ashish K. Jha MD MPH (@ashishkjha) April 15 2021  ACIP's decision to wait would be fine if there was no pandemic going on But there is And waiting 7-10 days won't do much. Not sure what data they will get in that time But we'll have done real harm to a terrific vaccine particularly well-suited for vulnerable populations 6/7 â€” Ashish K. Jha MD MPH (@ashishkjha) April 15 2021  Weâ€™re in a pandemic Short pause to alert folks is reasonable Waiting when its unlikely to change what we know is not J&J highly-effective safe vaccine with rare side-effects I'd make it available soon particularly for those for whom alternatives are not good choices Fin â€” Ashish K. Jha MD MPH (@ashishkjha) April 15 2021  Jhaâ€™s also worried about rural recipients having to do without J&J. Rural areas are redder politically and Republicans are vaccine-skeptical to an alarming degree in polls lately: Roughly 45 percent say that theyâ€™re unlikely to get the vaccine. Johnson & Johnson is the best chance at getting them to roll the dice because itâ€™s a single shot and doesnâ€™t use the novel mRNA technology that may put some risk-averse people off. And now thanks to the pause those Republicans have special reason to be wary of J&J too. Iâ€™m glad Trump rode to J&Jâ€™s defense a few days ago at least. Maybe he can help rebuild confidence in their product. 
